Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early

Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early

Act Now for Your ACS Patients: Treat Aggressively, Combine and Start Early

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Caprini Score Responses to Prevent VTE in Patients Undergoing Varicose Vein Surgery

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.